Medicure Tests Heart-Bypass Protectant
Posted on: Friday, 17 November 2006, 12:00 CST
Medicure said Friday it has begun enrolling up to 3,000 coronary bypass patients in a U.S./European phase 3 study of heart drug MC-1.
The company said its MEND-CABG II confirmatory study will assess the cardioprotective effects of the drug, which has been granted fast-track review status by the Food and Drug Administration.
There are currently no approved cardioprotective products to reduce cardiovascular events after CABG surgery, said Medicure President and CEO Albert Friesen. MC-1 has the opportunity to be the first such product available to help the hundreds of thousands of patients undergoing CABG surgery every year.
The MEND-CABG trial will take place at roughly 120 cardiac surgical centers throughout North America and Europe, the company said.
Patients will receive placebo or MC-1 250 mg prior to surgery and for 30 days post operatively. Researchers will then assess reduction in cardiovascular death and non-fatal myocardial infarction up to 30 days post-op with a 90-day post-op follow-up.
Source: United Press International
Related Articles
- Telephone-Delivered Care For Treating Depression After CABG Surgery Appears To Improve Outcomes
- Licorice gargle may help surgery patients
- Guidelines Enhance Safety for Bariatric Surgery Patients
- Bariatric Surgery Patients Have 65 Percent Lower Chance of Complications at Top-Performing Hospitals: HealthGrades Study
- HealthGrades Study: Bariatric Surgery Patients Have Fewer Complications at High-Volume Hospitals
- Cosmetic Surgery Patients Give Public First Glimpse of 'New Look' at Fall Fashion Show
- FDA Advisory Committee Strongly Endorses Use of Trasylol(R) in CABG Surgery Patients
- Brain Surgery Patient Dies, Others Alerted
- Trasylol (Aprotinin Injection) Reduced Bleeding and Transfusion Requirements in Patients on Clopidogrel Who Required Coronary Artery Bypass Graft (CABG) Surgery
- Nabi Biopharmaceuticals Announces Initiation of New StaphVAX(R) Immunogenicity Study in Orthopedic Surgery Patients
 |
 |
User Comments (0)
RSS Feeds